SCHEMBL23958176

SCHEMBL23958176

COc1cc(F)cc2c(=O)n(-c3ccccc3)c(Nc3cccnc3)nc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALPL P05186 2/20 0.39
G6PD P11413 1/20 0.39
MAPT P10636 3/20 0.38
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 2/20 0.38
RAB9A P51151 2/20 0.38
POLB P06746 1/20 0.38
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.38
ALOX12 P18054 1/20 0.38
PIK3CD O00329 1/20 0.38
TSHR P16473 2/20 0.38
NPC1 O15118 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KMT2A Q03164 4/20 0.37
MEN1 O00255 3/20 0.36
USP2 O75604 2/20 0.36
CYP1A2 P05177 2/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24090085 0.91 ALDH1A1 (0.42) MAPTALDH1A1KDM4ERAB9APOLB
SCHEMBL24111001 0.88 PIK3CD (0.41) MAPTALDH1A1ALOX12PIK3CDKMT2A
SCHEMBL30103287 0.88 PIK3CD (0.41) MAPTALDH1A1ALOX12PIK3CDKMT2A
SCHEMBL23958352 0.86 G6PD (0.44) G6PDMAPTALDH1A1KDM4ERAB9A
SCHEMBL29738614 0.81 PIK3CD (0.46) POLBALOX12PIK3CDKMT2AABCG2
SCHEMBL23958265 0.81 PIK3CD (0.46) POLBALOX12PIK3CDKMT2AABCG2
SCHEMBL24110803 0.80 ALOX12 (0.40) MAPTALDH1A1RAB9APOLBALOX12
SCHEMBL23958283 0.80 HTR7 (0.46) ALPLMAPTPOLBLMNA
SCHEMBL30103195 0.80 HTR7 (0.46) ALPLMAPTPOLBLMNA
SCHEMBL23958201 0.79 ALOX12 (0.43) MAPTADORA2AADORA1ALOX12KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2021-12-16 US disclosed
WO-2021215537-A1 2-HETEROARYLAMINOQUINAZOLINONE DERIVATIVE 大日本住友製薬株式会社 (JP) 2021-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE CRKL, CLIC4, CLIC1 ALPL 4100/4885G6PD 1971/4885MAPT 4749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.